<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/572042EC-CCDD-43EC-ADA9-8ECA3B62C42B"><gtr:id>572042EC-CCDD-43EC-ADA9-8ECA3B62C42B</gtr:id><gtr:firstName>Gerard</gtr:firstName><gtr:surname>Graham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EEE5331C-7D11-4578-BAC5-788C990A6C47"><gtr:id>EEE5331C-7D11-4578-BAC5-788C990A6C47</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:surname>McInnes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2D6F6946-D55B-43F7-A0F5-D4556B5B4D86"><gtr:id>2D6F6946-D55B-43F7-A0F5-D4556B5B4D86</gtr:id><gtr:firstName>Foo</gtr:firstName><gtr:otherNames>Yew</gtr:otherNames><gtr:surname>Liew</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E26696FF-6082-498A-B077-79D7CD503F94"><gtr:id>E26696FF-6082-498A-B077-79D7CD503F94</gtr:id><gtr:firstName>Xiaoqing</gtr:firstName><gtr:surname>Wei</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1D1F3958-6DFE-49F9-8228-9ECDAA7825B6"><gtr:id>1D1F3958-6DFE-49F9-8228-9ECDAA7825B6</gtr:id><gtr:firstName>Alirio</gtr:firstName><gtr:otherNames>Jose</gtr:otherNames><gtr:surname>Melendez Romero</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801198"><gtr:id>274D5976-9BBE-4193-A532-25B7F28E7778</gtr:id><gtr:title>Molecular and functional characterization of the novel cytokine IL-35</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801198</gtr:grantReference><gtr:abstractText>We have recently reported the finding of a new protein called IL-35 which can potently suppress experimental rheumatoid arthritis. We now wish to exploit this discovery and translate it into clinical applications. To do so, we need to know much more about the characteristic of this molecule. This project is designed to do so. We have assembled a team of experts in the fields of molecular biology, cellular immunology and clinical trials, together with international collaborations. We hold intellectual property right to IL-35 and are in negotiation with a biotech company to develop IL-35 as a therapeutic reagent. We believe that this project will not only lead to greater understanding of the basic knowledge of how our immune system works but also to a potent therapeutic agent against some of the major diseases impacting on global health and economy.</gtr:abstractText><gtr:technicalSummary>We have recently reported (1) the finding of the novel cytokine, IL-35, which enhanced the proliferation of regulatory T (Treg) cells and suppressed the development of Th17. Furthermore, IL-35 attenuated collagen-induced arthritis in mice and was detected in the diseased-joints of patients with rheumatoid arthritis (RA). IL-35 was also recently reported to be produced by Treg cells (2). Thus IL-35 represents an exciting novel therapeutic agent against a range of inflammatory diseases. However, little is known about the molecular mechanism of action and its role in other diseases. We propose here to investigate the molecular nature of IL-35 in vivo, IL-35 receptor and the signaling pathway of IL-35. We will also explore the role of IL-35 in a number of key infection and inflammatory disease models. Finally, we will investigate the role of IL-35 in clinical RA. We have assembled a team of leading experts in the fields of molecular, cellular and system biology to focus on this project, together with international collaborators who are specialists in the field of infection and inflammation. We will employ the latest technologies available, including gene targeting, cell imaging, siRNA and proteomics. We also have extensive clinical trial facilities and experience and we hold the intellectual property right of IL-35 and have a close working relationship with a biotech company. Thus, this project could rapidly lead to clinical applications of IL-35 to some of the major infectious and inflammatory diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2012-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>733950</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>235000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>915CAD09-EE79-43CD-8F71-D4E897312020</gtr:id><gtr:outcomeId>hX9KUdpnbER0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ED607DD2-D279-4C9D-B16D-3C09B7837BC7</gtr:id><gtr:title>Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf4678bffdcb0cafd313bbf3b4880bb"><gtr:id>2bf4678bffdcb0cafd313bbf3b4880bb</gtr:id><gtr:otherNames>Gabriele L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_14749_29_23608732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87F21A63-49B8-4EDD-8E64-19CD839BCA5C</gtr:id><gtr:title>Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66e55afa75dfc7d5c2db77933d53682c"><gtr:id>66e55afa75dfc7d5c2db77933d53682c</gtr:id><gtr:otherNames>Yang CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>09A3175B6EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9141EBA-7373-441C-892E-A9CE87B2FD39</gtr:id><gtr:title>Disease-associated functions of IL-33: the new kid in the IL-1 family.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d903f48e79964a5d02e098b694a592d"><gtr:id>0d903f48e79964a5d02e098b694a592d</gtr:id><gtr:otherNames>Liew FY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>GYHdrvv7xcD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30FC62DF-9296-4E92-A577-D76099230DA5</gtr:id><gtr:title>Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8c81b946dab25d016d4ae274f7b8944"><gtr:id>a8c81b946dab25d016d4ae274f7b8944</gtr:id><gtr:otherNames>Asquith DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>pFWg1h1tZcb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94FD4623-AB39-411B-A8A9-411E0B4B7D13</gtr:id><gtr:title>Role of IL-18 in overt pain-like behaviour in mice.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>66BA012F90A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0493D7D-6A74-414E-88E1-9BAFCB8B34B0</gtr:id><gtr:title>IL-33 exacerbates eosinophil-mediated airway inflammation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1dd6e8e73c5e2b9b06df32a959a783b"><gtr:id>a1dd6e8e73c5e2b9b06df32a959a783b</gtr:id><gtr:otherNames>Stolarski B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>m8pA27idsD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E06C71E-6486-4253-8F70-5A9EB13A60B8</gtr:id><gtr:title>IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6382940be00966049fbb664f03fba32"><gtr:id>d6382940be00966049fbb664f03fba32</gtr:id><gtr:otherNames>Turnquist HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>588b603661f996.48447773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD94B49A-F16A-4756-A917-6FEFF7A3624A</gtr:id><gtr:title>IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/181788d1197fdc4cae30985077b49b51"><gtr:id>181788d1197fdc4cae30985077b49b51</gtr:id><gtr:otherNames>Salmond RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_14749_29_22738676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2939429B-3E7E-47A2-AF93-8C732E259D37</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5CC4EAEDBDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82641FBF-12AB-4686-AD91-51127879A403</gtr:id><gtr:title>The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d0729b1b2fbb5a4d15e19c73abc497f"><gtr:id>3d0729b1b2fbb5a4d15e19c73abc497f</gtr:id><gtr:otherNames>Sesti-Costa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14749_29_23733876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4219CBEC-2B7C-46E0-AEB2-465B5205FDF9</gtr:id><gtr:title>IL-33 attenuates EAE by suppressing IL-17 and IFN-? production and inducing alternatively activated macrophages.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2a2fc1758d2867fc19fb4fd882fa28f"><gtr:id>f2a2fc1758d2867fc19fb4fd882fa28f</gtr:id><gtr:otherNames>Jiang HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_14749_29_22585447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13DEBDAB-8A56-43AF-9AB5-1084EBC5B93A</gtr:id><gtr:title>MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14749_29_21690378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FA50B42-C2D6-47B6-966B-E39C8B28CF34</gtr:id><gtr:title>Role of interleukin 33 in human immunopathology.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12deb286400a96352b1d739d0d0d7575"><gtr:id>12deb286400a96352b1d739d0d0d7575</gtr:id><gtr:otherNames>Murphy GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>oyyPEvcUWgD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>345A322D-1A4B-4AC8-A0E2-36E57477F875</gtr:id><gtr:title>IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>jDAkByJ6ST5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F18CD17-9F5B-4B65-8B52-2D7C89B937D6</gtr:id><gtr:title>Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e225fcd06d8aceca5dfde99685bb18c"><gtr:id>4e225fcd06d8aceca5dfde99685bb18c</gtr:id><gtr:otherNames>Alves-Filho JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>cu378J3xbdr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>211E580E-5C85-480A-B548-99EFB80D4F7C</gtr:id><gtr:title>A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>Aqv4ccWrvLa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>932CD133-23ED-4186-9236-4C6CE9BFDE34</gtr:id><gtr:title>CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2502a8b0dccd8fbf755f5604c236841"><gtr:id>a2502a8b0dccd8fbf755f5604c236841</gtr:id><gtr:otherNames>Grespan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>16E3DE8379D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A1E48B2-721C-42DE-8CB0-5BF381423D5E</gtr:id><gtr:title>IL-33 exacerbates autoantibody-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>PHXUHRPbD1W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE3B87E-F0C4-4CD1-9182-33C8AECBE5BA</gtr:id><gtr:title>IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/575fe53874a5674190be0b00b681e5ab"><gtr:id>575fe53874a5674190be0b00b681e5ab</gtr:id><gtr:otherNames>Zaiss MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>UE62WpxhSSX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BB25A35-D68D-4E59-BE9B-642A992D2F1B</gtr:id><gtr:title>IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6382940be00966049fbb664f03fba32"><gtr:id>d6382940be00966049fbb664f03fba32</gtr:id><gtr:otherNames>Turnquist HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14749_29_21949025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B443932B-CD24-40BC-B35C-FB06F7EBA938</gtr:id><gtr:title>Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2a2fc1758d2867fc19fb4fd882fa28f"><gtr:id>f2a2fc1758d2867fc19fb4fd882fa28f</gtr:id><gtr:otherNames>Jiang HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>B3BBF30E52F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A54CF11-427A-4DB8-8526-53FD4C5E464B</gtr:id><gtr:title>Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>EqaKpQ1pLru</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>553F1E8D-2C57-456A-91AD-BF0BAA9C527A</gtr:id><gtr:title>Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf5399a7d50fc64e4536fee66c538aec"><gtr:id>cf5399a7d50fc64e4536fee66c538aec</gtr:id><gtr:otherNames>Lemos HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>PFRmY38Cj6w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69C806DC-745E-4B24-A6B9-0F0A60901607</gtr:id><gtr:title>The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn><gtr:outcomeId>pm_14749_29_21356240</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E1CEA31-11DE-4453-BDC3-2745082C4DE8</gtr:id><gtr:title>Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pyRV41ap1Xi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F879F8B-4CD5-404D-9E36-F1477F1ADE3A</gtr:id><gtr:title>IL-33 activates B1 cells and exacerbates contact sensitivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>L6D8mzqYFVt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>575F8B28-020A-4840-9581-7EDBC7E00F61</gtr:id><gtr:title>Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in na&amp;iuml;ve mice.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>pm_14749_29_22702477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7494DF86-CDB4-41FA-A886-30D4A1E25CB6</gtr:id><gtr:title>IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c67da887a938fbf22b16b3305eeaf91"><gtr:id>8c67da887a938fbf22b16b3305eeaf91</gtr:id><gtr:otherNames>Zarpelon AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14749_29_23347081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C99D1C0-76A2-4A94-A375-15C0854C01F2</gtr:id><gtr:title>TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bfc2f1098958f434a6850f39a3c07f4"><gtr:id>0bfc2f1098958f434a6850f39a3c07f4</gtr:id><gtr:otherNames>Trieu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>384D702F198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C17FC488-F3A3-47A9-BEF2-B9279418001F</gtr:id><gtr:title>What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?</gtr:title><gtr:parentPublicationTitle>Journal of clinical periodontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d824e354badbb295816a45a36878f1f8"><gtr:id>d824e354badbb295816a45a36878f1f8</gtr:id><gtr:otherNames>Culshaw S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-6979</gtr:issn><gtr:outcomeId>pm_14749_29_21323707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA04244A-B7A0-4C95-B9FC-4A71620DAA01</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>588b2239982602.83155467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2293020-3FEF-4019-AAB4-F4CCC40B6444</gtr:id><gtr:title>IL-33 reduces the development of atherosclerosis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>2A546A40FFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3107C32-D34C-449D-B02F-3C42B1F4BF6D</gtr:id><gtr:title>IL-33 reduces macrophage foam cell formation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7404c9ae8e2c662f4f25c5bfd1c6a84"><gtr:id>d7404c9ae8e2c662f4f25c5bfd1c6a84</gtr:id><gtr:otherNames>McLaren JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>sVGf4FK7BAg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5CDB2E3-43F8-4406-9938-DCB4F2DE8374</gtr:id><gtr:title>An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.</gtr:title><gtr:parentPublicationTitle>Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9610041be7243589a3de52ccc8754eb4"><gtr:id>9610041be7243589a3de52ccc8754eb4</gtr:id><gtr:otherNames>Magro DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0100-879X</gtr:issn><gtr:outcomeId>pm_14749_29_23903682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E87C791D-16AF-42E2-8EA2-EFD2E265DA1C</gtr:id><gtr:title>IL-33 induces skin inflammation with mast cell and neutrophil activation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886abf362db80f502c90ad76ccc80c2e"><gtr:id>886abf362db80f502c90ad76ccc80c2e</gtr:id><gtr:otherNames>Hueber AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_14749_29_21674479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC493A73-4367-4D40-8046-7FDF53A075B1</gtr:id><gtr:title>IL-33 exacerbates antigen-induced arthritis by activating mast cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>ffrHRkchhtQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>297414A5-96BF-4307-A117-F92D4162647C</gtr:id><gtr:title>Interleukin-33 and the function of innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76a9c296c0e07da4d0fb0e98d30823d5"><gtr:id>76a9c296c0e07da4d0fb0e98d30823d5</gtr:id><gtr:otherNames>Mirchandani AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_14749_29_22609147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4637DB4B-95C4-49D1-867B-2BB8E227BDF7</gtr:id><gtr:title>Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology.</gtr:title><gtr:parentPublicationTitle>Journal of clinical periodontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/659360bec0ab428cd6ce9f5ded5d69da"><gtr:id>659360bec0ab428cd6ce9f5ded5d69da</gtr:id><gtr:otherNames>Kinane DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-6979</gtr:issn><gtr:outcomeId>pm_14749_29_21323703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63ADD988-D28F-4F31-9621-AEA03561257C</gtr:id><gtr:title>IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>68D3A1916A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E239434C-A4FB-4E9A-BE86-F17C1F98BD38</gtr:id><gtr:title>IL-33: a Janus cytokine.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d903f48e79964a5d02e098b694a592d"><gtr:id>0d903f48e79964a5d02e098b694a592d</gtr:id><gtr:otherNames>Liew FY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>pm_14749_29_22460136</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C6697F8-A02F-4D7C-BA38-54745756D31E</gtr:id><gtr:title>Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14749_29_23720815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BBAEF7A-41B8-4D8C-BFBC-929701AA70EF</gtr:id><gtr:title>Regulation of type 17 helper T-cell function by nitric oxide during inflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Euset25DHLk</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801198</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>